1 |
D. M. Walsh, I. Klyubin, J. V. Fadeeva, W. K. Cullen, R. Anwyl, M. S. Wolfe, M. J. Rowan, and D. J. Selkoe, "Intracerebroventricular administration of amyloid -protein oligomers selectively increases dorsal hippocampal dialysate glutamate levels in the awake rat", Nature, Vol. 416, pp. 535-539, 2002.
DOI
ScienceOn
|
2 |
P. Picone, R. Carrotta, G. Montana, M. R. Nobile, P. L. S. Biagio, and M. Di Carlo, "A oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures", Biophysical J., Vol. 96, pp. 4200-4211, 2008.
|
3 |
C. M. Troy, S. A. Rabacchi, W. J. Friedman, T. F. Frappier, K. Brown, and M.L. Shelanski, "Caspase-2 mediates neuronal cell death induced by -amyloid", J Neurosci., Vol. 20, pp. 1386-1392, 2000.
|
4 |
J. Harada and M. Sugimoto, "Activation of caspase-3 in -amyloid induced apoptosis of cultured rat cortical neurons", Brain Res., Vol. 842, pp. 311-323, 1999.
DOI
ScienceOn
|
5 |
I. Klyubin, D. M. Walsh, C. A. Lemere, W. K. Cullen, G. M. Shankar, C. Betts, E. T. Spooner, K. Jiang, R. Anwyl, D. J. Selkoe, and M. J. Rowan, "Movement disorders: Neurodevelopment and neurobehavioural expression", Nat. Med., Vol. 11, pp. 556-561, 2005.
DOI
|
6 |
C. S. Goldsbury, G. J. Cooper, K. N. Goldie, S. A. Muller, E.L. Saafi, W.T. Gruijters, M.P. Misur, A. Engel, U. Aebi, and J. Kistler, "Polymorphic fibrillar assembly of human amylin", J. Struct. Biol., Vol. 119, pp. 17-27, 1997.
DOI
|
7 |
P. L. Whitney and C. Tanford, "Solubility of amino acids in aqueous urea solutions and its implications for the denaturation of proteins by urea", J. Biol. Chem., Vol. 237, pp. 1735-1737, 1962.
|
8 |
C. Hyde, T. Johnson, D. Owen, M. Quibell, and R.C. Sheppard, "Some 'difficult sequences' made easy. A study of interchain association in solidphase peptide synthesis", Int. J. Pept. Protein Res., Vol. 43, pp. 431-440, 1994.
|
9 |
R. T. Baker, A. M. Catanzariti, Y. Karunasekara, T.A. Soboleva, R. Sharwood, S. Whitney, and P.G. Board, "Using deubiquitylating enzymes as research tools", Methods Enzymol., Vol. 398, pp. 540-554, 2005.
DOI
ScienceOn
|
10 |
R. J. Jenny, K. G. Mann, and R. L. Lundblad, "A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa", Protein Expr. Purif., Vol. 31, pp. 1-11, 2003.
DOI
ScienceOn
|
11 |
P. A. Nygren, S. Stahl, and M. Uhlen, "Engineering proteins to facilitate bioprocessing", Trends Biotechnol., Vol. 12, pp. 184-188, 1994.
DOI
ScienceOn
|
12 |
A. K. Tickler, C. J. Barrow, and J. D. Wade, "Improved preparation of amyloid-beta peptides using DBU as Nalpha-Fmoc deprotection reagent", J. Pept. Sci., Vol. 7, pp. 488-494, 2001.
DOI
|
13 |
D. J. Seloke, "Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease", Annu. Rev. Cell Biol., Vol. 10, pp. 373-403, 1994.
DOI
ScienceOn
|
14 |
D. T. Loo, A. Copani, C. J. Pike, E. R. Whittemore, A. J. Walencewicz, and C. W. Cotman, "Apoptosis is induced by -amyloid in cultured central nervous system neurons", Proc. Natl. Acad. Sci. USA, Vol. 90, pp. 7951-7955, 1993.
DOI
ScienceOn
|
15 |
K. J. Ivins and E. T. N. Bui, "Cotman CW. -amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis", Neurobiol. Dis. Vol. 5, pp. 365-378, 1998.
DOI
ScienceOn
|
16 |
C. Stadelmann, W. Bruck, C. Bancher, K. Jellinger, and H. Lassmann, "Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis", J. Neuropathol. Exp. Neurol., Vol. 57, pp. 456-464, 1998.
DOI
ScienceOn
|
17 |
T. Pillot, B. Drouet, S. Queille, C. Labeur, J. Vandekerckhove, M. Rosseneu, M. Pincon-Raymond, and J. Chambaz, "The nonfibrillar amyloid peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain", J. Neurochem., Vol. 73, pp. 1626-1634, 1999.
|
18 |
N. K. Robakis, N. Ramakrishna, G. Wolfe, and H.M. Wisniewski, "Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides", Proc. Natl. Acad. Sci. USA, Vol. 84, pp. 4190-4194, 1987.
DOI
ScienceOn
|
19 |
B. Solomon, R. Koppel, D. Frankel, and E. Hanan- Aharon, "Disaggregation of Alzheimer beta-amyloid by site-directed mAb", Proc. Natl. Acad. Sci. USA, Vol. 94, pp. 4109-4112, 1997.
DOI
|
20 |
Y. Su, C. L. Chang, S. S. Lee, W. C. Chen, and C. F. Huang, "In vitro cytotoxic activity of 1- decarboxy-3-oxo-ceanothic acid in a human ovarian adenocarcinoma cell line", Res. Commun. Mol. Pathol. Pharmacol., Vol. 100, pp. 313-326, 1998.
|
21 |
R. Vassar, B. D. Bennett, S. Babu-Khan, S. Kahn, E. A. Mendiaz, P. Denis, D. B. Teplow, S. Ross, P. Amarante, R. Loeloff, Y. Luo, S. Fisher, J. Fuller, S. Edenson, J. Lile, M.A. Jarosinski, A.L. Biere, E. Curran, T. Burgess, J. C. Louis, F. Collins, J. Treanor, G. Rogers, and M. Citron, "beta-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE", Science, Vol. 286, pp. 735-741, 1999.
DOI
ScienceOn
|
22 |
M. S. Wolfe, W. Xia, B. L. Ostaszewski, T. S. Diehl, W.T. Kimberly, and D. J. Selkoe, "Two transmembrane aspartates in presenilin-1 required for presenilin endoproteo-lysis and gamma-secretase activity", Nature, Vol. 398, pp. 513-517, 1999.
DOI
|
23 |
S. J. Wood, B. Maleeff, T. Hart, and R. Wetzel, "Physical morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Ab", J. Mol. Biol., Vol. 256, pp. 870-877, 1996.
DOI
ScienceOn
|
24 |
T. Yamazaki, E. H. Koo, and D. J. Selkoe, "Trafficking of cell-surface amyloid beta-protein precursor. II. Endocytosis, recycling and lysosomal targeting detected by immunolocalization", J. Cell Sci., Vol. 109, pp. 999-1008, 1996.
|
25 |
M. D. Kane, R. D. Schwarz, L. S. Pierre, M. D. Watson, M. R. Emmerling, P. A. Boxer, and G. K. Walker, "Inhibitors of V-Type ATPases, bafilomycin A1 and concanamycin A, protect against amyloidmediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-razolium bromide (MTT) reduction", J. Neurochem., Vol. 72, pp. 1939-1947, 1999.
|
26 |
E. H. Koo and S. L. Squazzo, "Evidence that production and release of amyloid beta-protein involves the endocytic pathway", J. Biol. Chem., Vol. 269, pp. 17386-17389, 1994.
|
27 |
D. Burdick, B. Soreghan, M. Kwon, J. Kosmoski, M. Knauer, A. Henschen, J. Yates, C. Cotman, and C. Glabe, "Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs", J. Biol. Chem., Vol. 267, pp. 546-554, 1992.
|
28 |
P. T. Chang and Y. Su, "Protocol for qualitative analysis of the in vitro aggregation of synthetic beta-amyloid: A method applicable to the identification of substances that may have therapeutic efficacy for Alzheimer's disease", Brain Res. Protoc., Vol. 6, pp. 6-12, 2000.
DOI
|
29 |
L. Giovannelli, C. Scali, M.S. Faussone-Pellegrini, G. Pepeu, and F. Casamenti, "Long-term changes in the aggregation state and toxic effects of betaamyloid injected into the rat brain", Neuroscience, Vol. 87, pp. 349-357, 1998.
DOI
|
30 |
M.P. Lambert, A.K. Barlow, B.A. Chromy, C. Edwards, R. Freed, M. Liosatos, T.E. Morgan, I. Rozovsky, B. Trommer, K.L. Viola, P. Wals, C. Zhang, C.E. Finch, G.A. Krafft, and W.L. Klein, "Diffusible, nonfibrillar ligands derived from Ab1-42 are potent central nervous system neurotoxins", Proc. Natl. Acad. Sci. USA, Vol. 95, pp. 6448-6453, 1998.
DOI
ScienceOn
|
31 |
G.A. MacGibbon, G.J. Cooper, and M. Dragunow, "Acute application of human amylin, unlike betaamyloid peptides, kills undifferentiated PC12 cells by apoptosis", NeuroReport, Vol. 8, pp. 3945-3950, 1997.
DOI
|
32 |
M.M. Pallitto, J. Ghanta, P. Heinzelman, L.L. Kiessling, and R.M. Murphy, "Recognition sequence design for peptidyl modulators of bamyloid aggregation and toxicity", Biochemistry, Vol. 38, pp. 3570-3578, 1999.
DOI
ScienceOn
|
33 |
W. Garzon-Rodriguez, M. Sepulveda-Becerra, S. Milton, and C. G. Glabe, "Amyloid -peptide polymerization studied using fluorescence correlation spectroscopy", J. Biol. Chem., Vol. 272, pp. 21037-21044, 1997.
DOI
|
34 |
A. J. Patel, S. Gunasekera, A. Jen, and H. A. R de Silva, "b-Amyloid-mediated inhibition of redox activity (MTT reduction) is not an indicator of astroglial degeneration", NeuroReport, Vol. 7, pp. 2026-2030, 1996.
DOI
|
35 |
C. J. Pike, A. J. Walencewicz, C. G. Glabe, and C. W. Cotman, "In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity", Brain Res., Vol. 563, pp. 311-314, 1991.
DOI
|
36 |
B. Soreghan, J. Kosmoski, and C. Glabe, "Observation of metastable amyloid protofibrils by atomic force microscopy", J. Biol. Chem., Vol. 269, pp. 28551-28554, 1994.
|
37 |
D. M. Walsh, A. Lomakin, G. B. Benedek, M. M. Condron, and D. B. Teplow, "Amyloid -protein fibrillogenesisstructure and biological activity of protofibrillar intermediates", J. Biol. Chem., Vol. 272, pp. 22364-22372, 1997.
DOI
ScienceOn
|
38 |
H. A. Lashuel, D. Hartley, B. M. Petre, T. Walz, and P. T. Lansbury, Jr, "Dissociation of amyloid fibrils of -synuclein and transthyretin by pressure reveals their reversible nature and the formation of waterexcluded cavities", Nature, Vol. 418, pp. 291, 2002.
|
39 |
M. Anguiano, R. J. Nowak, and P. T. Lansbury, Jr, "Membrane interaction of islet amyloid polypeptide", Biochemmistry, Vol. 41, pp. 11338-11343, 2002.
DOI
|
40 |
A. Lomakin, D.B. Teplow, D. A. Kirschner, and G. B. Benedek, "Kinetic theory of fibrillogenesis of amyloid-protein", Proc. Natl. Acad. Sci. USA, Vol. 94, pp. 7942-7947, 1997.
DOI
|
41 |
S. Barghorn, V. Nimmrich, A. Striebinger, C. Krantz, P. Keller, B. Janson, M. Bahr, M. Schmidt, R. S. Bitner, J. Harlan, E. Barlow, U. Ebert, and H. Hillen, "Artificial proteases toward catalytic drugs for amyloid diseases", J. Neurochem., Vol. 95, pp. 834-847, 2005
DOI
ScienceOn
|
42 |
M. P. Lambert, a. K. Barlow, B. A. Chromy, C. Edwards, R. Freed, M. Liosatos, T. E. Morgan, I. Rozovsky, B. Trommer, K. L. Viola, P. Wals, C. Zhang, C. E. Finch, G. A. Krafft, and W. L. Klein, "Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins", Proc. Natl. Acad. Sci. USA, Vol. 95, pp. 6448-6453, 1998.
DOI
ScienceOn
|
43 |
M. Bucciantini, E. Giannoni, F. Chiti, F. Baroni, L. Formigli, J. Zurdo, N. Taddei, G. Ramponi, C. M. Dobson, and M. Stefani, "Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases", Nature, Vol. 416, pp. 507-511, 2002.
DOI
ScienceOn
|
44 |
S. Lesne, M. T. Koh, L. Kotilinek, R. Kayed, C. G. Glabe, A. Yang, M. Gallagher, and K. H. Ashe, "A specific amyloid-beta protein assembly in the brain impairs memory", Nature, Vol. 440, pp. 352-357, 2006.
DOI
ScienceOn
|
45 |
M. A Westerman, D. Cooper-Blacketer, A. Mariash, L. Kotilinek, T. Kawarabayashi, L. H. Younkin, G. A. Carlson, S. G. Younkin, and K. H. Ashe, J. Neurosci., "The relationship between and memory in the Tg2576 mouse model of Alzheimer's disease", Vol. 22, pp. 1858-1867, 2002.
|
46 |
H. M. Wisniewski and R. D. Terry, "Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers", Prog. Neuropathol. Vol. 2, pp. 1-26, 1973.
|
47 |
J. Hardy and D. J Selkoe, "The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics", Science, Vol. 297, pp. 353-356, 2002.
DOI
ScienceOn
|
48 |
L. F. Lue, Y. M. Kuo, A. E. Roher, L. Brachova, Y. Shen, L. Sue, T. Beach, J. H. Kurth, R. E. Rydel, and J. Rogers, "Soluble amyloid peptide concentration as a predictor of synaptic change in Alzheimer's disease", Am. J. Pathol., Vol. 155, pp. 853-862, 1999.
DOI
ScienceOn
|
49 |
L. M. Billings, S. Oddo, K. N. Green, J. L. McGaugh, and F. M. Laferla, "Intraneuronal causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice", Neuron, Vol. 45, pp. 675-688, 2005.
DOI
ScienceOn
|
50 |
C. A. Mclean, R. A. Cherny, F. W. Fraser, S. J. Fuller, M. J. Smith, K. Beyreuther, A. I. Bush, and C. L. Masters, "The redox chemistry of the Alzheimer's disease amyloid peptide", Ann. Neurol., Vol. 46, pp. 860-866, 1999.
DOI
|
51 |
S. Baglioni, F. Casamenti, M. Bucciantini, L. M. Luheshi, N. Taddei, F. Chiti, C. M. Dobson, and M. Stefani, "Prefibrillar Amyloid Aggregates Could Be Generic Toxins in Higher Organisms", J. Neurosci., Vol. 26, pp. 8160-8167, 2006.
DOI
ScienceOn
|
52 |
C. Haass and D. J. Selkoe, "Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide", Nat. Mol. Cell Biol., Vol. 8, pp. 101-112, 2007.
DOI
ScienceOn
|
53 |
D. Burdick, B. Soreghan, M. Kwon, J. Kosmoski, M. Knauer, A. Henschen, J. Yates, C. Cotman, and C. Glabe, "A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state", J. Biol. Chem., Vol. 267, pp. 546-554, 1992.
|
54 |
C. Hilbich, B. Kisters-Woike, J. Reed, C. L. Masters, and K. Beyreuther, "The interaction of betaamyloid protein fragment (12-28) with lipid environments", J. Mol. Biol., Vol. 218, pp. 149-163, 1991.
DOI
|
55 |
J. D. Harper, S. S. Wong, C. M. Lieber, and P. T. Lansbury, "Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid- protein", Chem. Biol., Vol. 4, pp. 119-125, 1997.
DOI
ScienceOn
|
56 |
D. A. Kirschner, C. Abraham, and D. J. Selkoe, "Xray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation", Proc. Natl. Acad. Sci. USA, Vol. 83, pp. 503-507 1986.
DOI
|
57 |
R. D. Terry, "The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis", J. Neuropathol. Exp. Neurol., Vol. 55, pp. 1023-1025, 1996.
DOI
|
58 |
J. P. Cleary, D. M. Walsh, J. J. Hofmeister, G. M. Shankar, M. A. Kuskowski, D. J. Selkoe, and K. H. Ashe, "Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function", Nat. Neurosci., Vol. 8, pp. 79-84, 2005.
DOI
ScienceOn
|
59 |
A. M. Catanzariti, T. A. Soboleva, D.A. Jans, P. G. Board, and R.T. Baker, "An efficient system for high-level expression and easy purification of authentic recombinant proteins", Protein Sci., Vol. 13, pp. 1331-1339, 2004.
DOI
ScienceOn
|
60 |
G. Rimon, C. E. Bazenet, K. L. Philpott, and L. L. Rubin, "Increased surface phosphatidylserine is an early marker of neuronal apoptosis", J. Neurosci. Res., Vol. 48, pp. 563-570, 1997.
DOI
|